Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Teva
McKinsey
Queensland Health
US Army
Boehringer Ingelheim
Baxter
Covington

Generated: April 22, 2018

DrugPatentWatch Database Preview

ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE Drug Profile

« Back to Dashboard

When do Alphacaine Hydrochloride W/ Epinephrine patents expire, and when can generic versions of Alphacaine Hydrochloride W/ Epinephrine launch?

Alphacaine Hydrochloride W/ Epinephrine is a drug marketed by Carlisle and is included in two NDAs.

The generic ingredient in ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE
Drug patent expirations by year for ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE

US Patents and Regulatory Information for ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Carlisle ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084720-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Carlisle ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084732-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Cipla
Covington
Baxter
AstraZeneca
Boehringer Ingelheim
Citi
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.